We analyzed possible correlations between the different isoprostanoids families (isoprostanes, neuroprotanes, dihomo-isoprostanes) (Figure S1), and CSF AD-specific biomarkers (Aβ, t-Tau, p-Tau) in order to establish a possible relationship between oxidative stress (brain grey and white matter damage) and amyloid pathology. The gene discussed is MAPT; the disease is Alzheimer disease.